Pharmaceuticals United States Page 3 - biotechnology pharmaceutical development

BioNumerik is a leader in a powerful new area called "mechanism-based" drug discovery, which employs multi-disciplinary science, including chemistry, biology and quantum physics, integrated with high performance computational technologies, to identify ...

WraSer Pharmaceuticals is an emerging pharmaceutical company that identifies, develops, and markets proprietary pharmaceutical products to physicians and pharmacies throughout the United States. WraSer's professional, results-oriented staff, combined with ...

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting ...

Guilford Pharmaceuticals Inc. was founded in July 1993 by Scios Nova Inc., Dr. Solomon H. Snyder and Dr. Craig R. Smith to discover and develop novel pharmaceutical and biopolymer-based products that are intended to offer new and better treatments for ...

SIGA Technologies, Inc. (SIGA) is a biotechnology company that discovers, develops and commercializes anti-infectives for serious infectious diseases. The major focus of the Company's developmental and commercialization activities is on products for use ...

"Bone Care International, Inc. is an innovative pharmaceutical company dedicated to improving patient outcomes by delivering unsurpassed Vitamin D hormone therapies. Bone Care International, Inc. is committed to discovering, developing and commercializing ...

Montigen will discover and develop novel promising compounds for license or co-development with select pharmaceutical and biotechnology partners. The company will also utilize its proprietary technology in partnership with select partners. Our primary ...

NimbleGen Systems (http://www.nimblegen.com/) is the leading supplier of custom-designed high-density microarray products and services, offering unprecedented flexibility for genomics research. NimbleGen's Maskless Array Synthesis (MAS) technology combines ...

BIO BALANCE INC., a New York corporation, founded in 1993, is engaged in studies of biomedical problems. The philosophy behind Bio Balance is that accurate descriptions of drug-receptor interactions will lead to the development of better pharmaceuticals ...

Montigen will discover and develop novel promising compounds for license or co-development with select pharmaceutical and biotechnology partners. The company will also utilize its proprietary technology in partnership with select partners. Our primary ...

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting ...

Scientific Protein Laboratories (SPL) has been a leading global supplier of high quality active pharmaceutical ingredients (APIs) for nearly three decades. We specialize in cGMP biopharmaceutical manufacturing and are among the largest commercial suppliers ...

Cellegy Pharmaceuticals, Inc. (Cellegy) is a specialty pharmaceutical company engaged in the development and commercialization of prescription drugs targeting primarily women’s health care, including the reduction in transmitting of human immunodeficiency ...

Air Products (NYSE: APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940 ...

At Cutanix, we are committed to carrying out comprehensive studies to ensure the safety of our products. All of our products are subjected to a rigorous toxicology testing program similar to that required by the FDA for prescription drugs. While such testing ...

CGI Pharmaceuticals, Inc. is a private, development-stage pharmaceutical company that has leveraged its proprietary chemistry and kinase biology expertise to discover and develop an innovative pipeline of small molecule therapeutics for multiple oncology ...

Quorex Pharmaceuticals is discovering and developing first-in-class drugs to address the growing unmet need for new and effective therapies to treat serious bacterial infections. The company's proven discovery engine is making it possible to discover highly ...

Scientific Protein Laboratories (SPL) has been a leading global supplier of high quality active pharmaceutical ingredients (APIs) for nearly three decades. We specialize in cGMP biopharmaceutical manufacturing and are among the largest commercial suppliers ...

Commonwealth Biotechnologies, Inc. (CBI) is a specialized life sciences outsourcing business that offers expertise and a complete range of discovery chemistry and biology products and services, through its subsidiary companies. The subsidiaries of the ...

Bioaccelerate is a drug development company that acquires late discovery and early clinical products, develops these products to the next stage, builds therapeutic companies and delivers value through product and company transactions. Through our financial ...

Helix BioMedix, Inc. is a biopharmaceutical company with a library of structurally bioactive peptides and patents covering hundreds of thousands of peptide sequences. The Company has developed short, small-chain peptides with anti-infective, anti-inflammatory ...

Bioenvision's primary focus is the acquisition, development, distribution and marketing of compounds and technologies for the treatment of cancer. Bioenvision has a broad pipeline of products for the treatment of cancer, including: Evoltra(TM), Modrenal(R ...

Chemeq Limited is an Australia-based veterinary pharmaceutical company, in the business of developing, manufacturing and marketing its product, CHEMEQ polymeric anti-microbial (CHEMEQ), for the prevention and control of intestinal bacterial diseases in ...

Providers of drug delivery system in Hightstown

BioNumerik is a leader in a powerful new area called "mechanism-based" drug discovery, which employs multi-disciplinary science, including chemistry, biology and quantum physics, integrated with high performance computational technologies, to identify ...